Figure 5.
Effects of ONCOS-102 and pembrolizumab on number of liver nodules in each mouse at time of sacrifice (day 40). Data represent mean ± SEM. Groups: 1–6 had 8 animals/group, groups: 7–8 had 6 animals/group.
Effects of ONCOS-102 and pembrolizumab on number of liver nodules in each mouse at time of sacrifice (day 40). Data represent mean ± SEM. Groups: 1–6 had 8 animals/group, groups: 7–8 had 6 animals/group.